The involvement of p62–Keap1–Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity

• Published in: Free radical biology & medicine Vol. 85; pp. 12 - 23
• Main Authors: Ji, Li-Li, Sheng, Yu-Chen, Zheng, Zhi-Yong, Shi, Liang, Wang, Zheng-Tao
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2015
• Subjects: Cell Line; Hepatotoxicity; Humans; Intracellular Signaling Peptides and Proteins - metabolism; JNK; Keap1; Kelch-Like ECH-Associated Protein 1; Liver - drug effects; Liver - metabolism; MAP Kinase Kinase 4 - metabolism; NF-E2-Related Factor 2 - genetics; NF-E2-Related Factor 2 - metabolism; Nrf2; Oxidation-Reduction; p62; Quercetin; Quercetin - pharmacology; RNA-Binding Proteins - metabolism; Signal Transduction; Transcriptional Activation - drug effects; APAP; JNK; HO-1; MAPK; p62; TSN; GCLC; ERK1/2; ARE; Nrf2; Cliv; Quer; CCl4; ROS; Quercetin; Keap1; GCLM; Hepatotoxicity; ZnPP; BSO
• ISSN: 0891-5849; 1873-4596
• DOI: 10.1016/j.freeradbiomed.2015.03.035

Quercetin, one of the most abundant dietary flavonoids, is reported to have protective function against various hepatotoxicant-induced hepatotoxicity. The present study aims to investigate the critical role of the nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidative signaling pathway in the protection of quercetin against hepatotoxicity. Quercetin prevented the cytotoxicity induced by a variety of hepatotoxicants including clivorine (Cliv), acetaminophen (APAP), ethanol, carbon tetrachloride (CCl4), and toosendanin (TSN) in human normal liver L-02 cells. Quercetin induced the nuclear translocation of Nrf2, along with the increased expression of the antioxidant responsive element (ARE)-dependent genes like catalytic or modify subunit of glutamate-cysteine ligase (GCLC/GCLM), and heme oxygenase-1 (HO-1). In addition, the HO-1 inhibitor zinc protoporphyrin (ZnPP) and the GCL inhibitor L-buthionine-(S,R)-sulfoximine (BSO) both reduced the hepatoprotection induced by quercetin. Quercetin had no effect on kelch-like ECH-associated protein-1(Keap1) expression, but molecular docking results indicated the potential interaction of quercetin with the Nrf2-binding site in Keap1 protein. Quercetin increased the expression of p62, and p62 siRNA decreased quercetin-induced hepatoprotection. Quercetin induced the activation of c-Jun N-terminal kinase (JNK) in hepatocytes. JNK inhibitor SP600125 and JNK siRNA both reduced quercetin-induced hepatoprotection. SP600125 and JNK siRNA decreased the increased p62 expression induced by quercetin. In addition, SP600125 also decreased the increased mRNA and protein expression of GCLC, GCLM, and HO-1 induced by quercetin. Taken together, our present study demonstrates that quercetin prevents hepatotoxicity by inducing p62 expression, inhibiting the binding of Keap1 to Nrf2, and thus leading to the increased expression of antioxidative genes dependent on Nrf2. Meanwhile, our study indicates that JNK plays some regulation in this process. [Display omitted] •Quercetin protects against hepatotoxicity.•Quercetin activates the NRF2–ARE antioxidative signaling pathway.•Quercetin interacts with the binding site of Nrf2 in Keap1 protein.•P62 plays an important role in regulating the protection of quercetin against hepatotoxicity.•JNK plays an important role in regulating the protection of quercetin against hepatotoxicity.